2236 related articles for article (PubMed ID: 15515479)
1. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
2. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
[TBL] [Abstract][Full Text] [Related]
3. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A
Bratisl Lek Listy; 2004; 105(10-11):368-73. PubMed ID: 15658577
[TBL] [Abstract][Full Text] [Related]
4. Effects of diabetes mellitus, age, and duration of dialysis on parathormone in chronic hemodialysis patients.
Nasri H; Kheiri S
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):608-13. PubMed ID: 18580021
[TBL] [Abstract][Full Text] [Related]
5. Association of white blood cell count with left ventricular hypertrophy and ejection fraction in stable hemodialysis patients.
Nasri H
Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):31-6. PubMed ID: 17237888
[TBL] [Abstract][Full Text] [Related]
6. Correlation of serum parathormone with hypertension in chronic renal failure patients treated with hemodialysis.
Baradaran A; Nasri H
Saudi J Kidney Dis Transpl; 2005; 16(3):288-92. PubMed ID: 17642794
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis.
Baradaran A; Nasri H
Saudi J Kidney Dis Transpl; 2006 Sep; 17(3):344-50. PubMed ID: 16970254
[TBL] [Abstract][Full Text] [Related]
9. Association between white blood cell count and levels of serum homocysteine in end-stage renal failure patients treating with hemodialysis.
Bradran A; Nasri H
J Ayub Med Coll Abbottabad; 2006; 18(1):22-6. PubMed ID: 16773964
[TBL] [Abstract][Full Text] [Related]
10. A long-term, multicenter study of the efficacy and safety of paricalcitol in end-stage renal disease.
Lindberg J; Martin KJ; González EA; Acchiardo SR; Valdin JR; Soltanek C
Clin Nephrol; 2001 Oct; 56(4):315-23. PubMed ID: 11680662
[TBL] [Abstract][Full Text] [Related]
11. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients.
Sit D; Kadiroglu AK; Yilmaz ME; Kara IH; Isikoglu B
Ren Fail; 2005; 27(4):403-7. PubMed ID: 16060127
[TBL] [Abstract][Full Text] [Related]
12. Left ventricular hypertrophy in hypertensive type 2 diabetic patients according to renal function.
Blanchet Deverly A; Kangambega P; Hue K; Donnet JP; Merault H; Foucan L
Diabetes Metab; 2009 Sep; 35(4):280-6. PubMed ID: 19423378
[TBL] [Abstract][Full Text] [Related]
13. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
[TBL] [Abstract][Full Text] [Related]
14. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
Gu Y; Ding F; Chen N; Mei CL; Qian JQ; Wang XY; Shi W; Hou FF; Li XW; Wang M; Chen YP
Ren Fail; 2005; 27(2):205-12. PubMed ID: 15807187
[TBL] [Abstract][Full Text] [Related]
15. [Hyperthyroidism, therapy with erythropoietin, malnutrition and systolic function in hemodialysis: echocardiography study].
Iannetti E; Carpinteri G; Vitale M; Squatrito R; Catalano D; Trovato GM
Recenti Prog Med; 2000 Dec; 91(12):632-5. PubMed ID: 11194481
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and risk factors of myocardial remodeling in hemodialysis patients.
Dimitrijevic Z; Cvetkovic T; Stojanovic M; Paunovic K; Djordjevic V
Ren Fail; 2009; 31(8):662-7. PubMed ID: 19817519
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of TNF-alpha in left ventricular remodeling in hemodialysis patients.
Nishimura M; Hashimoto T; Kobayashi H; Fukukda T; Okino K; Yamamoto N; Nakamura N; Yoshikawa T; Takahashi H; Ono T
J Nephrol; 2003; 16(5):641-9. PubMed ID: 14733409
[TBL] [Abstract][Full Text] [Related]
18. ACE gene polymorphism, left ventricular geometry, and mortality in diabetic patients with end-stage renal disease.
Sakka Y; Babazono T; Sato A; Ujihara N; Iwamoto Y
Diabetes Res Clin Pract; 2004 Apr; 64(1):41-9. PubMed ID: 15036826
[TBL] [Abstract][Full Text] [Related]
19. [Serum osteocalcin in children with chronic renal insufficiency].
Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
[TBL] [Abstract][Full Text] [Related]
20. [The comparison of selected parameters of structure and function of the cardiovascular system in patients with functioning graft on maintenance hemodialysis during a one year period].
Króliczak M; Stompór T; Sułowicz W; Ochmański W; Królczyk J
Przegl Lek; 2001; 58(10):894-902. PubMed ID: 11957815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
